Skip to content
OpenCapital
Get started

NovoCure NVCR Market capitalization

Market capitalization at other companies

Boston Scientific logo
Boston ScientificBSX
$93.26B-37.5%
Medtronic logo
MedtronicMDT
$103.96B-3.8%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$1.45B+32.4%
Nuvation Bio logo
Nuvation BioNUVB
$1.49B+150%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$1.43B+61.1%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$1.02B+62.1%

Other financials

Income statement

See full
Revenue$174.1M+12.3%
Gross profit$135.1M+16.0%
Operating income-$67.4M-78.1%
Net income-$71.1M-107%
EPS (diluted)-$0.62-100%

Balance sheet

See full
Cash & equivalents$87.5M-31.2%
Total debt$39.5M-2.1%
Total equity$330.7M-8.6%
Total assets$787.9M-36.9%

Cash flow

See full
Operating cash flow-$13.5M+62.1%
CapEx$5.2M-51.4%
Free cash flow-$18.7M+59.7%

Valuation

See full
Enterprise value$1.59B-36.3%
P/S2.4×-1.7×

Profitability

See full
Gross margin75.2%-2.0pp
Operating margin-27.2%+0.4pp
Net margin-25.7%-0.7pp
FCF margin-7.1%-2.0pp

Returns & leverage

See full
Return on equity-50%+5.4pp
Debt / equity0.1×0.0×
Current ratio2.9×+1.4×

Where this comes from

Computed from the period-end share price: $1.24B.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NovoCure's market capitalization?
NovoCure (NVCR) reported market capitalization of $1.24B in Q1 2026.
How has NovoCure's market capitalization changed year-over-year?
NovoCure's market capitalization decreased by 36.7% year-over-year, from $1.96B to $1.24B.
What is the long-term trend for NovoCure's market capitalization?
Over 5 years (2020 to 2025), NovoCure's market capitalization has grown at a -39.6% compound annual growth rate (CAGR), from $17.96B to $1.45B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.